By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Therapeutic breakthroughs require novel methods of target discovery. Doloromics is harnessing a clinically validated human-first platform approach to improve probabilities of success throughout the early development lifecycle.
Our mission is to deliver patient relief with precision medicines
We have generated the largest privately held multi-omic database of human sensory tissue. This enables Doloromics' Neuro-immune Cartography, yielding a high-fidelity molecular roadmap of disease condition-specific therapeutic targets.
Our Value Proposition
Who We Are: World-Class Domain Expertise
Our team comprises innovative thinking, deep neuroscience and pharmacological knowledge, and proven pharmaceutical industry experience to pioneer an entirely new way of discovering and developing better, safer therapeutics for patients.
What We Do: Precision Medicines for Targeted Disease Modification
Our therapeutic pipeline is prospectively designed to address root causes of diseases leading to imbalances in the neuro-immune axis, so that we can design and deliver the right medicine for the right patient across a broad spectrum of mechanistically distinct chronic diseases.
How We Do It: Best-in-Class Discovery Engine
We start with human disease tissues and multi-omically elucidate key drivers of neuro-immune dysregulation. We then employ proprietary technologies to validate the relevant targets and the clinical candidates designed to modulate them.